10 Most Popular Funds in January 2017 (Taiwan Domiciled)

10 Most Searched for Taiwan Domiciled Funds by tw.morningstar.com users

Morningstar Editors 15 February, 2017 | 11:16
Facebook Twitter LinkedIn

1. Yuanta Global ETFs Stable Fund of Funds

Morningstar Category: Global Large-Cap Blend Equity
Morningstar Rating (2017-01-31):Stars 3

2. Allianz Global Investors Target Income Fund B TWD

Morningstar Category: High Yield Bond - Other Hedged
Morningstar Rating (2017-01-31): Not Rated

3. ABITL Global High Yield Fund TA TWD

Morningstar Category: High Yield Bond - Other Hedged
Morningstar Rating (2017-01-31):Not Rated

4. Taishin High Dividend Yield Balanced Fund                           

Morningstar Category: TWD Moderate Allocation

Morningstar Rating (2017-01-31):Stars 5

5. ABITL Global High Yield Fund TA RMB

Morningstar Category: High Yield Bond - Other Hedged
Morningstar Rating (2017-01-31):Not Rated

6. PineBridge Global Multi-Strategy High Yield Bond Fund B TWD

Morningstar Category: Global High Yield Bond
Morningstar Rating (2017-01-31):Stars 2

7. UBS (TW) Bond Fund - Asian High Yield - B

Morningstar Category: Asia High Yield Bond
Morningstar Rating (2017-01-31):Stars 3

8. Allianz Global Investors Global Biotech Fund TWD

Morningstar Category: Sector Equity Biotechnology
Morningstar Rating (2017-01-31):Stars 3

9. SinoPac CSI 300 Dividend Index Fund

Morningstar Category: China Equity - A Shares
Morningstar Rating (2017-01-31):Stars 4

10. Fuh Hwa Digital Economy Fund

Morningstar Category: Sector Equity Technology
Morningstar Rating (2017-01-31):Stars 4

 

 

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. 

 

 

Facebook Twitter LinkedIn

About Author

Morningstar Editors  -

© Copyright 2022 Morningstar Asia Ltd. All rights reserved.

Terms of Use        Privacy Policy